• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国各实验室间/2变异解读能力的综合评估。

Comprehensive evaluation of /2 variant interpretation ability among laboratories in China.

作者信息

Shao Kang, Wang Ruixia, Qu Shoufang, Zhang Wenxin, Yu Ting, Cao Boyang, Dai Pingping, Zhu Anna, Zhang Jianguang, Wang Juan, Wang Lusheng, Zhu Shida, Wu Kui, Yang Xuexi, Chang Xiaoyan, Chen Fang, Huang Jie

机构信息

BGI-Shenzhen, Shenzhen, China.

Department of Computer Science, City University of Hong Kong, Kowloon, Hong Kong.

出版信息

J Med Genet. 2022 Mar;59(3):230-236. doi: 10.1136/jmedgenet-2020-107360. Epub 2021 Jan 4.

DOI:10.1136/jmedgenet-2020-107360
PMID:33397747
Abstract

High-quality interpretation of variants plays a critical role in the clinical practice of precision medicine. However, a comprehensive system to evaluate the quality and accuracy of variant interpretation has yet to be established. This study investigates the performance of an interpretation system in evaluating the capacities of interpretation among distinct laboratories in China. The evaluation system is based on a reference database that contains 750 different variants in / Evaluation was performed among 41 laboratories in China. We classified their performance into five levels. Only level A was considered qualified. This level allows for a 0.3% error rate for clinical decision-related misinterpretation; 26 of 41 laboratories (63%) met the qualified standard, while 7 laboratories were at levels D and E, which indicated egregious mistakes and systemic problems in variant interpretation. Due to strict quality demands, the interpretation of several variants was amended, which largely influenced the quality rate. The number of qualified laboratories would decrease from 26 to 17 if those incorrect recommended interpretations were not corrected. This evaluation system provides a potential approach for standardisation of variant interpretation and lowers the discordance of variant interpretation between different laboratories. A well-designed interpretation ability evaluation is essential to evaluate the interpretation level of laboratories before they provide service in real-world clinical settings.

摘要

高质量的变异解读在精准医学的临床实践中起着关键作用。然而,尚未建立一个全面的系统来评估变异解读的质量和准确性。本研究调查了一个解读系统在中国不同实验室评估解读能力方面的表现。该评估系统基于一个包含750种不同变异的参考数据库。在中国的41个实验室中进行了评估。我们将它们的表现分为五个等级。只有A级被认为合格。这个等级允许临床决策相关误读的错误率为0.3%;41个实验室中有26个(63%)达到了合格标准,而7个实验室处于D级和E级,这表明在变异解读中存在严重错误和系统性问题。由于严格的质量要求,对几个变异的解读进行了修正,这在很大程度上影响了质量率。如果不纠正那些错误的推荐解读,合格实验室的数量将从26个减少到17个。这个评估系统为变异解读的标准化提供了一种潜在方法,并降低了不同实验室之间变异解读的不一致性。精心设计的解读能力评估对于在实验室在实际临床环境中提供服务之前评估其解读水平至关重要。

相似文献

1
Comprehensive evaluation of /2 variant interpretation ability among laboratories in China.中国各实验室间/2变异解读能力的综合评估。
J Med Genet. 2022 Mar;59(3):230-236. doi: 10.1136/jmedgenet-2020-107360. Epub 2021 Jan 4.
2
Discrepancies in Genetic Testing Procedures of BRCA1/2 Mutations: A National Survey Across China.BRCA1/2 基因突变基因检测程序的差异:中国全国范围内的一项调查。
Mol Diagn Ther. 2020 Dec;24(6):715-721. doi: 10.1007/s40291-020-00489-0.
3
Variant classification changes over time in BRCA1 and BRCA2.BRCA1 和 BRCA2 中的变异分类随时间变化。
Genet Med. 2019 Oct;21(10):2248-2254. doi: 10.1038/s41436-019-0493-2. Epub 2019 Apr 11.
4
Comprehensive profiling of BRCA1 and BRCA2 variants in breast and ovarian cancer in Chinese patients.中国患者乳腺癌和卵巢癌中 BRCA1 和 BRCA2 变异的全面分析。
Hum Mutat. 2020 Mar;41(3):696-708. doi: 10.1002/humu.23965. Epub 2019 Dec 24.
5
Data sharing to improve concordance in variant interpretation across laboratories: results from the Canadian Open Genetics Repository.数据共享以提高实验室间变异解释的一致性:来自加拿大开放遗传资源库的结果。
J Med Genet. 2022 Jun;59(6):571-578. doi: 10.1136/jmedgenet-2021-107738. Epub 2021 Apr 19.
6
Data sharing as a national quality improvement program: reporting on BRCA1 and BRCA2 variant-interpretation comparisons through the Canadian Open Genetics Repository (COGR).数据共享作为一项国家质量改进计划:通过加拿大开放遗传资源库(COGR)报告 BRCA1 和 BRCA2 变异解读比较情况。
Genet Med. 2018 Mar;20(3):294-302. doi: 10.1038/gim.2017.80. Epub 2017 Jul 20.
7
Reliable assessment of BRCA1 and BRCA2 germline variants by next-generation sequencing: a multicenter study.基于新一代测序的 BRCA1 和 BRCA2 种系变异的可靠评估:一项多中心研究。
Breast Cancer. 2021 May;28(3):672-683. doi: 10.1007/s12282-020-01204-x. Epub 2021 Jan 5.
8
Characterization of BRCA1 and BRCA2 splicing variants: a collaborative report by ENIGMA consortium members.BRCA1 和 BRCA2 剪接变异体的特征:ENIGMA 联盟成员的协作报告。
Breast Cancer Res Treat. 2012 Apr;132(3):1009-23. doi: 10.1007/s10549-011-1674-0. Epub 2011 Jul 19.
9
Assessment of Interlaboratory Variation in the Interpretation of Genomic Test Results in Patients With Epilepsy.评估癫痫患者基因组检测结果解读中的实验室间变异。
JAMA Netw Open. 2020 Apr 1;3(4):e203812. doi: 10.1001/jamanetworkopen.2020.3812.
10
BRCA1 and BRCA2 genetic testing-pitfalls and recommendations for managing variants of uncertain clinical significance.BRCA1和BRCA2基因检测——处理临床意义不确定变异的陷阱与建议
Ann Oncol. 2015 Oct;26(10):2057-65. doi: 10.1093/annonc/mdv278. Epub 2015 Jul 7.

引用本文的文献

1
Multigene germline and somatic testing for epithelial ovarian cancer in China.中国上皮性卵巢癌的多基因种系和体细胞检测
NPJ Precis Oncol. 2025 Aug 13;9(1):281. doi: 10.1038/s41698-025-01074-6.